Open AccessP867: TUMOR PROFILING OF IDECABTAGENE VICLEUCEL (IDE‐CEL; BB2121) PATIENTS IN KARMMA SHOWED COMPARABLE RESPONSES IN EXISTING MOLECULAR HIGH‐RISK SUBSETS AND PRELIMINARY GENE SIGNATURE OF DURABLE RESPONSE
Author(s) -
Martin N.,
Xu A.,
Stong N.,
Rytlewski J.,
Finney O.,
Campbell T.,
Pierceall W.,
Flynt E.,
Thompson E.,
Kaiser S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846348.62497.10
Subject(s) - transcriptome , cancer research , gene , malignancy , medicine , gene signature , oncology , biology , gene expression , genetics